Home
Conditions
Recurrent Ovarian Cancer

Clinical trial condition

Recurrent Ovarian Cancer

Explore clinical trials studying Recurrent Ovarian Cancer. Study availability and eligibility vary by location and protocol.

32 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Ovarian Cancer trial results

Completed

Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer

NCT01809379

Conditions: Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +17 more
Locations: Ruhr University Bochum Bochum, North Rhine-Westphalia, Germany

View Trial Details

Completed

Safety and Efficacy Study of Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian Cancer

NCT02303912

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +19 more
Locations: Garry Weston Cancer Centre, Hammersmith Hospital London, United Kingdom

View Trial Details

Completed

Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer

NCT03430518

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +18 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Completed

H.O.P.E: Helping Ovarian Cancer Patients Cope

NCT02090582

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations: University of North Carolina Chapel Hill, North Carolina, United States

Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian Cancer

NCT02849353

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Fuda cancer institute of Fuda cancer hospital Guangzhou, Guangdong, China

View Trial Details

Completed

Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

NCT01381861

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

University of California, San Diego La Jolla, California, United States

University of Southern California Los Angeles, California, United States

Palm Beach Cancer Institute West Palm Beach, Florida, United States

View Trial Details

Completed

An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer

NCT01869400

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Praxis und Tagesklinik für gynäkologische Onkologie Ebersberg, Bavaria, Germany

Diakoniekrankenhaus, Gynäkologie und Geburtshilfe Rotenburg (Wümme), Lower Saxony, Germany

View Trial Details

Completed

Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian Cancer

NCT01637532

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Leiden University Medical Center Leiden, Netherlands

View Trial Details

Completed

Interactive Educational Website for Women With Ovarian Cancer & Caregivers

NCT01626014

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer

NCT01639885

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Leiden University Medical Center Leiden, Netherlands

View Trial Details

Recurrent Ovarian Cancer

Recurrent Ovarian Cancer trial results

Related conditions